{"schema_version":"alpha-company-profile-public-v2","slug":"4d-molecular-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc","published_on":"2026-09-06T06:32:22.234968+00:00","last_reviewed_on":"2026-09-06T06:32:22.234968+00:00","identity":{"legal_name":"4D Molecular Therapeutics, Inc.","display_name":"4D Molecular Therapeutics, Inc.","headline":"Canonical company identity and public leadership record.","description":"Alpha's canonical identity and public leadership record for 4D Molecular Therapeutics, Inc..","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001650648","logo":"https://cdn.brandfetch.io/ticker/fdmt/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/fdmt/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"4D Molecular Therapeutics, Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-06T06:32:22.234968+00:00"},"security_listings":[{"ticker":"FDMT","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"4D Molecular Therapeutics, Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/4d-molecular-therapeutics-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-06T06:32:22.234968+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":18,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":18,"corroborated_claims":0,"sources":4,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-06T06:32:22.234968+00:00","observed_at":"2026-09-06T06:32:22.234968+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"4d-molecular-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc"},"publication":{"published_at":"2026-09-06T06:32:22.234968+00:00","last_reviewed_at":"2026-09-06T06:32:22.234968+00:00","as_of":"2026-09-06T06:32:22.234968+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/4d-molecular-therapeutics-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"4d-molecular-therapeutics-inc","canonical_url":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc","as_of":"2026-09-06T06:32:22.234968+00:00","last_reviewed_at":"2026-09-06T06:32:22.234968+00:00","identity":{"legal_name":"4D Molecular Therapeutics, Inc.","display_name":"4D Molecular Therapeutics, Inc.","description":null,"jurisdiction":null,"country":"US","sector":null,"industry":null,"website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001650648","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"FDMT","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"040aa1c6-90f1-48b4-9e7c-54a8d0d89748","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-12","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"john-f-milligan-fdmt","display_name":"John F. Milligan","role_category":"director","title":"Director and Executive Chairman","committee":null,"is_board_chair":true,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001140361-26-017427","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T06:32:22.234968+00:00"},"headshot_url":null},{"person_slug":"charles-theuer-fdmt","display_name":"Charles Theuer","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2015-01-01","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A ny20063669x1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T02:47:21.946347+00:00"},"headshot_url":null},{"person_slug":"david-kirn","display_name":"David Kirn","role_category":"director","title":"Director, President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001140361-26-017427","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T06:32:22.234968+00:00"},"headshot_url":null},{"person_slug":"david-kirn-m-d","display_name":"David Kirn, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2013-01-01","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A ny20063669x1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T02:47:21.946347+00:00"},"headshot_url":null},{"person_slug":"glenn-sblendorio-fdmt","display_name":"Glenn Sblendorio","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-01-01","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A ny20063669x1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T02:47:21.946347+00:00"},"headshot_url":null},{"person_slug":"jacob-chacko","display_name":"Jacob Chacko","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001140361-26-017427","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T06:32:22.234968+00:00"},"headshot_url":null},{"person_slug":"nancy-miller-rich-fdmt","display_name":"Nancy Miller-Rich","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A ny20063669x1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T02:47:21.946347+00:00"},"headshot_url":null},{"person_slug":"shawn-cline-tomasello-fdmt","display_name":"Shawn Cline Tomasello","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A ny20063669x1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T02:47:21.946347+00:00"},"headshot_url":null},{"person_slug":"susannah-gray-fdmt","display_name":"Susannah Gray","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2020-01-01","end_date":null,"verification_status":"unconfirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A ny20063669x1_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_proxy","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-02T02:47:21.946347+00:00"},"headshot_url":null}],"executives":[{"person_slug":"christopher-simms","display_name":"Christopher Simms","role_category":"executive","title":"Chief Commercial and Business Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001140361-26-017427","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T06:32:22.234968+00:00"},"headshot_url":null},{"person_slug":"david-kirn","display_name":"David Kirn","role_category":"executive","title":"President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001140361-26-017427","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T06:32:22.234968+00:00"},"headshot_url":null},{"person_slug":"david-kirn-m-d","display_name":"David Kirn, M.D.","role_category":"executive","title":"President, Chief Executive Officer and Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"FDMT DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_filing","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-05-04T22:57:09.523819+00:00"},"headshot_url":null},{"person_slug":"kristian-humer","display_name":"Kristian Humer","role_category":"executive","title":"Chief Financial Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001140361-26-017427","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T06:32:22.234968+00:00"},"headshot_url":null},{"person_slug":"scott-bizily","display_name":"Scott Bizily","role_category":"executive","title":"Chief Legal Officer and Corporate Secretary","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001140361-26-017427","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_def_14a","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-09-06T06:32:22.234968+00:00"},"headshot_url":null},{"person_slug":"scott-bizily-j-d-ph-d","display_name":"Scott Bizily, J.D., Ph.D.","role_category":"executive","title":"Chief Legal Officer and Corporate Secretary","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null,"verification_status":"confirmed","confidence":0.94,"evidence":{"document_title":"FDMT DEF 14A executive officers","source_url":"https://www.sec.gov/Archives/edgar/data/1650648/000114036126017427/ny20063669x1_def14a.htm","source_type":"sec_filing","published_at":"2026-04-28T00:00:00+00:00","effective_date":"2026-04-28","last_checked_at":"2026-05-04T22:57:11.669062+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc#profile","url":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc","dateModified":"2026-09-06T06:32:22.234968+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc#organization","legalName":"4D Molecular Therapeutics, Inc.","name":"4D Molecular Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Director and Executive Chairman","member":{"@type":"Person","name":"John F. Milligan","url":"https://registry.alpha.ac/people/john-f-milligan-fdmt"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2015-01-01","member":{"@type":"Person","name":"Charles Theuer","url":"https://registry.alpha.ac/people/charles-theuer-fdmt"}},{"@type":"OrganizationRole","roleName":"Director, President and Chief Executive Officer","member":{"@type":"Person","name":"David Kirn","url":"https://registry.alpha.ac/people/david-kirn"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2013-01-01","member":{"@type":"Person","name":"David Kirn, M.D.","url":"https://registry.alpha.ac/people/david-kirn-m-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2026-01-01","member":{"@type":"Person","name":"Glenn Sblendorio","url":"https://registry.alpha.ac/people/glenn-sblendorio-fdmt"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Jacob Chacko","url":"https://registry.alpha.ac/people/jacob-chacko"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Nancy Miller-Rich","url":"https://registry.alpha.ac/people/nancy-miller-rich-fdmt"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Shawn Cline Tomasello","url":"https://registry.alpha.ac/people/shawn-cline-tomasello-fdmt"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","member":{"@type":"Person","name":"Susannah Gray","url":"https://registry.alpha.ac/people/susannah-gray-fdmt"}},{"@type":"OrganizationRole","roleName":"Chief Commercial and Business Officer","member":{"@type":"Person","name":"Christopher Simms","url":"https://registry.alpha.ac/people/christopher-simms"}},{"@type":"OrganizationRole","roleName":"President and Chief Executive Officer","member":{"@type":"Person","name":"David Kirn","url":"https://registry.alpha.ac/people/david-kirn"}},{"@type":"OrganizationRole","roleName":"President, Chief Executive Officer and Director","startDate":"2026-04-28","member":{"@type":"Person","name":"David Kirn, M.D.","url":"https://registry.alpha.ac/people/david-kirn-m-d"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer","member":{"@type":"Person","name":"Kristian Humer","url":"https://registry.alpha.ac/people/kristian-humer"}},{"@type":"OrganizationRole","roleName":"Chief Legal Officer and Corporate Secretary","member":{"@type":"Person","name":"Scott Bizily","url":"https://registry.alpha.ac/people/scott-bizily"}},{"@type":"OrganizationRole","roleName":"Chief Legal Officer and Corporate Secretary","startDate":"2026-04-28","member":{"@type":"Person","name":"Scott Bizily, J.D., Ph.D.","url":"https://registry.alpha.ac/people/scott-bizily-j-d-ph-d"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/4d-molecular-therapeutics-inc"}},"canonical_source":"aegis_canonical"}